These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunotherapy in human glioblastoma. Szabo AT; Carpentier AF Rev Neurol (Paris); 2011 Oct; 167(10):668-72. PubMed ID: 21885075 [TBL] [Abstract][Full Text] [Related]
5. Progress in active-specific immunotherapy of brain malignancies. Tjoa BA; Salgaller ML Expert Opin Investig Drugs; 2000 Sep; 9(9):2093-101. PubMed ID: 11060795 [TBL] [Abstract][Full Text] [Related]
6. Vaccine for aggressive brain tumors may prolong survival. Health News; 2004 Dec; 10(12):7. PubMed ID: 15645564 [No Abstract] [Full Text] [Related]
7. Preface. Yang I; Lim M Neurosurg Clin N Am; 2010 Jan; 21(1):xv. PubMed ID: 19944961 [No Abstract] [Full Text] [Related]
8. [New directions in immunotherapy for malignant solid tumors]. Okuno K; Sugiura F; Sukegawa Y; Inoue K Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377 [TBL] [Abstract][Full Text] [Related]
9. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism. Nelson B Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750 [No Abstract] [Full Text] [Related]
10. Galectin-1 and immunotherapy for brain cancer. Verschuere T; De Vleeschouwer S; Lefranc F; Kiss R; Van Gool SW Expert Rev Neurother; 2011 Apr; 11(4):533-43. PubMed ID: 21469926 [TBL] [Abstract][Full Text] [Related]
11. New weapons against brain tumors. Emerging techniques from multi-national research curb the growth of brain tumors. Duke Med Health News; 2007 Oct; 13(10):5. PubMed ID: 18277427 [No Abstract] [Full Text] [Related]
12. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV. Toda M; Iizuka Y; Kawase T; Uyemura K; Kawakami Y Cancer Gene Ther; 2002 Apr; 9(4):356-64. PubMed ID: 11960286 [TBL] [Abstract][Full Text] [Related]
13. Cellular immunity in the treatment of brain tumors. Wheeler CJ; Yu JS; Black KL Clin Neurosurg; 2004; 51():132-9. PubMed ID: 15571138 [No Abstract] [Full Text] [Related]
14. [Neurosurgery and molecular biology: (series 10) gene therapy and biological therapy for brain tumors]. Okada H No Shinkei Geka; 1999 Jan; 27(1):9-17. PubMed ID: 10024979 [No Abstract] [Full Text] [Related]
15. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma. Everson RG; Graner MW; Gromeier M; Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS; Friedman AH; Bigner DD; Sampson JH Expert Rev Anticancer Ther; 2008 May; 8(5):717-32. PubMed ID: 18471045 [TBL] [Abstract][Full Text] [Related]
16. Increasing immunogenicity of cancer vaccines to improve their clinical outcome. Parmiani G; Cimminiello C; Maccalli C Expert Rev Vaccines; 2013 Oct; 12(10):1111-3. PubMed ID: 24124873 [No Abstract] [Full Text] [Related]
17. [Immunotherapy for brain tumor: don't get "Lost in Translation"]. Okada H No Shinkei Geka; 2005 May; 33(5):433-42. PubMed ID: 15912763 [No Abstract] [Full Text] [Related]
18. [III. Peptide vaccination therapy against brain tumors]. Hashimoto N; Kagawa N; Arita H; Tsuboi A; Oka Y; Oji Y; Sugiyama H; Yoshimine T Gan To Kagaku Ryoho; 2015 Jun; 42(6):687-9. PubMed ID: 26242006 [No Abstract] [Full Text] [Related]
20. The state of the art in non-small cell lung cancer immunotherapy. Seetharamu N Semin Thorac Cardiovasc Surg; 2014; 26(1):26-35. PubMed ID: 24952755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]